It known as a targeted therapy as it particularly targets the CD38  which are overexpressed about the multiple myeloma cells. Daratumumab is from a class of medicines called CD38 monoclonal antibodies. Wegovy is also approved to scale back the risk of coronary heart attacks, strokes, and cardiovascular death in adults with heart problems and who